Does semaglutide help prevent steroid-induced diabetes?

Researchers at Imperial College London would like to recruit adults living with prediabetes, or diagnosed with type 2 diabetes with HbA1c between 48 and 52 mmol/mol, to take part in a study that is looking to see how the diabetes drug, semaglutide, may prevent steroid-induced diabetes. 
Taking part involves five visits to Hammersmith Hospital in West London over three weeks. You'll be given the study medicines for seven days only. The visits will last one day and will involve blood tests after drinking a meal replacement drink. There will also be the option to do a second day, including more blood tests as part of an insulin clamp test and a fat and muscle biopsy. You'll also be asked to wear a glucose sensor for ten days before the study starts, and for another ten days while taking the study tablets. 
There is a payment of up to £750 for completing the whole trial (including optional second-day visits) to cover expenses and the inconvenience caused. For more information, please contact Dr Katharine Lazarus at imperial.steroids@nhs.net.